GlassScriptPhysician profile
Hormozd Bozorgchami
NPI 1174770382
$13,790.21
in general payments reported to CMS, 2019-2025
21 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,586 · 2020: $3,475 · 2021: $96.81 · 2022: $571 · 2023: $7,552 · 2024: $295 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,900 · Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,900.00 |
| Food and Beverage | $1,160.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mivi Neuroscience, INC. | $6,900.00 | 2023 | |
| Medical Device Business Services, INC. | $4,600.00 | 2019-2020 | |
| Stryker Corporation | $673.88 | 2019-2024 | Trevo, Transform |
| Qapel Medical INC | $331.47 | 2022-2024 | |
| Medtronic USA, INC. | $315.05 | 2019 | |
| Rapid Medical LTD | $212.98 | 2023 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Imperative Care, INC | $168.48 | 2022-2024 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Balt USA, LLC | $122.34 | 2025 | Ballast 088 Long Sheath |
| Medtronic, INC. | $109.19 | 2022 | |
| Novo Nordisk INC | $96.81 | 2021 | |
| Depuy Synthes Sales INC. | $74.05 | 2019-2023 | Emboguard, Embotrap |
| Abbvie INC. | $53.14 | 2025 | |
| Genentech USA, INC. | $47.37 | 2024-2025 | Activase, Ocrevus Zunovo, Ocrevus |
| Abbott Laboratories | $20.93 | 2023 | Xact |
| Lilly USA, LLC | $20.60 | 2025 | Amyvid, Kisunla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $16.00 | 2022 | |
| Curonix LLC | $14.05 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Asahi Intecc USA, INC. | $13.87 | 2024 | Peripheral Vascular |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hormozd Bozorgchami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.